Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

MLA

Harrysson, Sara, et al. Outcomes for Patients with Secondary CNS Involvement in Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Estimation of Eligibility for CAR T-Cell Therapy. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457643942&authtype=sso&custid=ns315887.

APA

Harrysson, S., Eloranta, S., Ekberg, S., Enblad, G., Andersson, P.-O., Sonnevi, K., Ljungqvist, M., Sander, B., Jerkeman, M., & Smedby, K. E. (2024). Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy.

Chicago

Harrysson, Sara, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, and Karin E. Smedby. 2024. “Outcomes for Patients with Secondary CNS Involvement in Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Estimation of Eligibility for CAR T-Cell Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1457643942&authtype=sso&custid=ns315887.